Relay Therapeutics (RLAY) Other Non Operating Income (2019 - 2026)

Relay Therapeutics (RLAY) has 8 years of Other Non Operating Income data on file, last reported at $5.3 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 32.1% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $23.8 million, a 29.28% decrease from a year earlier, with the FY2025 full-year figure at $26.3 million, down 24.46% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $5.3 million, down from $5.7 million in the prior quarter.
• Over the last five years, Other Non Operating Income for RLAY reached as high as $9.0 million in Q1 2024 and fell as low as $675000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $6.2 million across 5 years, with a median of $6.9 million in 2023.
• Across the five-year window, Other Non Operating Income surged 1903.0% in 2022 and plunged 36.04% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $5.3 million in 2022, then jumped by 62.7% to $8.7 million in 2023, then climbed by 3.15% to $9.0 million in 2024, then slumped by 36.04% to $5.7 million in 2025, then declined by 7.68% to $5.3 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $5.3 million in Q1 2026, $5.7 million in Q4 2025, and $6.2 million in Q3 2025.